Circadin, Retardtabletten
7680593110015
CH-59311
Tabletten
Associated product:
CIRCADIN cpr ret 2 mg 21 pce
1 / 3
google
Article details
- Package size
- 21
- Selling units
- 21
- Measure
- Tablette(n)
- Galenic form
- Tabletten
- Galenic group
- Tabletten
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
2.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
80.0 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
Authorization holder
NEURIM PHARMACEUTICALS AG
6312 Steinhausen
Authorization information
- Swissmedic authorization number
- 59311
- Drug name
- Circadin, Retardtabletten
- Galenic form
- RETT
- ATC Code
- N05CH01
- Authorization status
- Z
- Dispensing category
- B
- First authorization
- 09/11/2009
- Authorization expiration date
- 31/12/9999
- IT Number
- 01.03.1.
- Domain
- Human medicine
Package details
- Description (FR)
- CIRCADIN cpr ret 2 mg 21 pce
- Description (DE)
- CIRCADIN Ret Tabl 2 mg 21 Stk
- Market launch
- 09/11/2009
- Narcotic (BTM)
- No